BRIDGEBIO PHARMA INC (BBIO) Stock Cash Flow
NASDAQ:BBIO - Nasdaq - US10806X1028 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -676.79M | -543.35M | -653.25M | -484.65M | -586.45M | |||
| Depreciation Amortization | 5.76M | 6.08M | 6.49M | 6.77M | 5.84M | |||
| Change In Working Capital | 141.07M | 32.04M | 5.06M | 34.34M | -1.06M | |||
| Interest Paid | 79.30M | 91.34M | 61.11M | 54.44M | 29.77M | |||
| Other non cash items | 29.53M | -15.50M | 113.98M | 24.05M | 83.74M | |||
| OPERATING CASH FLOW | -500.42M | -520.73M | -527.72M | -419.49M | -497.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -9.01M | -8.91M | -1.31M | -6.32M | -13.25M | |||
| Other Investing Activity | 45.44M | 69.69M | 55.34M | 459.47M | -187.58M | |||
| INVESTING CASH FLOW | 36.43M | 60.78M | 54.03M | 453.15M | -200.83M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 588.49M | 449.07M | 0.00 | -20.49M | 1.08B | |||
| Stock Issued/Repurchased | -53.76M | 306.91M | 459.22M | 8.08M | -179.54M | |||
| Other Financing Activity | -5.49M | -7.53M | -7.68M | -720.00K | -163.70M | |||
| FINANCING CASH FLOW | 529.24M | 748.46M | 451.54M | -13.13M | 736.45M | |||
| CHANGE IN CASH | 65.25M | 288.51M | -22.15M | 20.53M | 37.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -500.42M | -520.73M | -527.72M | -419.49M | -497.93M | |||
| Capital Expenditure | -9.01M | -8.91M | -1.31M | -6.32M | -13.25M | |||
| FREE CASH FLOW | -509.44M | -529.63M | -529.03M | -425.81M | -511.18M | |||
All data in USD